Evidence map›Paper›PMID 18614026›Full record

ReviewNeuron2008

A role for brain stress systems in addiction.

George F Koob

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Neuron, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02771925 (Treatment for Alcohol Dependence With Gabapentin), which is not on this map. Cited by 561 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
561citing papers in PubMed, 3 pooled it
24.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02771925 phase4terminatednot on this mapstarted 2016, after this paper: background citation

Treatment for Alcohol Dependence With Gabapentin: A Double Blind Placebo Controlled Randomized Clinical Trial

TypeinterventionalSponsorDayanand Medical College and HospitalRan2016 to 2018Enrolled25ConditionsAlcohol DependenceArmsGabapentin 2g/day divided in two doses for 24 weeks, Placebo 2g/day divided in two doses for 24 weeks
3 · Its place in the literature

Who cites it

561 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,052 citations in OpenAlex.

  1. Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Pooled it
  2. Neural Underpinnings of Social Stress in Substance Use Disorders.Current topics in behavioral neurosciences · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. BLA kappa opioid receptor inputs to the BNST mediate social stress-induced increases in alcohol drinking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Antinociceptive Effect and Hyperalgesia of Fentanyl and Its Analogues.International journal of molecular sciences · 2026
    Article

501 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

George F KoobCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA. gkoob@scripps.edu
Scripps Research Institute · US

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI Remi Martin-Fardon · 2003 to 2026
$46.3M
TARGETED DISRUPTION OF NEUROENDOCRINE GENESP01DK026741 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI FISCHER, WOLFGANG H, RIVIER, JEAN E · 1986 to 2014
$31.6M
NEURONAL SUBSTRATES OF COCAINE REWARDR01DA004398 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI GEORGE, OLIVIER · 1987 to 2014
$4.9M
NEUROPHARMACOLOGY OF ETHANOL REINFORCEMENTR01AA008459 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI GEORGE, OLIVIER · 1990 to 2013
$4.2M
DOPAMINE PARTIAL AGONISTS AND PSYCHOSTIMULANT DEPENDENCER01DA010072 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KOOB, GEORGE F. · 1997 to 2011
$3.6M
CENTRAL MECHANISMS OF OPIATE REINFORCEMENT &DEPENDENCER01DA004043 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KOOB, GEORGE F. · 1986 to 2008
$3.0M
NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA008459NIDA NIH HHS R01 DA004043NIDA NIH HHS R01 DA004398NIDA NIH HHS R01 DA010072NIDDK NIH HHS P01 DK026741
6 · The paper itself

Abstract

Drug addiction is a chronically relapsing disorder characterized by compulsion to seek and take drugs and has been linked to dysregulation of brain regions that mediate reward and stress. Activation of brain stress systems is hypothesized to be key to the negative emotional state produced by dependence that drives drug seeking through negative reinforcement mechanisms. This review explores the role of brain stress systems (corticotropin-releasing factor, norepinephrine, orexin [hypocretin], vasopressin, dynorphin) and brain antistress systems (neuropeptide Y, nociceptin [orphanin FQ]) in drug dependence, with emphasis on the neuropharmacological function of extrahypothalamic systems in the extended amygdala. The brain stress and antistress systems may play a key role in the transition to and maintenance of drug dependence once initiated. Understanding the role of brain stress and antistress systems in addiction provides novel targets for treatment and prevention of addiction and insights into the organization and function of basic brain emotional circuitry.

Indexed as

AnimalsBrainHumansStress, PhysiologicalSubstance-Related Disorders

Identifiers

PMID18614026
PMCPMC2748830
OpenAlexW1991882455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.